Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-monthly subcutaneous Mircera maintenance study in pre-dialysis chronic renal anaemia
2008-003173-40Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Epoetin alfa RB in Uraemic Anaemia, sponsored by Roche. Primary endpoint: Proportion of patients maintaining average haemoglobin concentration during the EEP within the target range. Started Aug 2008; status: completed.
02
Drugs
Epoetin alfa RB
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2008-003173-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003173-40.